These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26821060)

  • 1. pH-responsive PepFect cell-penetrating peptides.
    Regberg J; Vasconcelos L; Madani F; Langel Ü; Hällbrink M
    Int J Pharm; 2016 Mar; 501(1-2):32-8. PubMed ID: 26821060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of a series of novel amphipathic cell-penetrating peptides.
    Regberg J; Srimanee A; Erlandsson M; Sillard R; Dobchev DA; Karelson M; Langel U
    Int J Pharm; 2014 Apr; 464(1-2):111-6. PubMed ID: 24463071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors.
    Lindberg S; Muñoz-Alarcón A; Helmfors H; Mosqueira D; Gyllborg D; Tudoran O; Langel U
    Int J Pharm; 2013 Jan; 441(1-2):242-7. PubMed ID: 23200958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saturated Fatty Acid Analogues of Cell-Penetrating Peptide PepFect14: Role of Fatty Acid Modification in Complexation and Delivery of Splice-Correcting Oligonucleotides.
    Lehto T; Vasconcelos L; Margus H; Figueroa R; Pooga M; Hällbrink M; Langel Ü
    Bioconjug Chem; 2017 Mar; 28(3):782-792. PubMed ID: 28209057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous membrane interaction of amphipathic peptide monomers, self-aggregates and cargo complexes detected by fluorescence correlation spectroscopy.
    Vasconcelos L; Lehto T; Madani F; Radoi V; Hällbrink M; Vukojević V; Langel Ü
    Biochim Biophys Acta Biomembr; 2018 Feb; 1860(2):491-504. PubMed ID: 28962904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of PepFect peptides for the delivery of splice-correcting oligonucleotides.
    Andaloussi SE; Lehto T; Lundin P; Langel U
    Methods Mol Biol; 2011; 683():361-73. PubMed ID: 21053143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-penetrating peptides recruit type A scavenger receptors to the plasma membrane for cellular delivery of nucleic acids.
    Juks C; Lorents A; Arukuusk P; Langel Ü; Pooga M
    FASEB J; 2017 Mar; 31(3):975-988. PubMed ID: 27881484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating peptides for siRNA delivery to glioblastomas.
    Srimanee A; Arvanitidou M; Kim K; Hällbrink M; Langel Ü
    Peptides; 2018 Jun; 104():62-69. PubMed ID: 29684592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histidine-Rich Cell-Penetrating Peptide for Cancer Drug Delivery and Its Uptake Mechanism.
    Zhang L; Xu J; Wang F; Ding Y; Wang T; Jin G; Martz M; Gui Z; Ouyang P; Chen P
    Langmuir; 2019 Mar; 35(9):3513-3523. PubMed ID: 30673275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation.
    Ezzat K; Andaloussi SE; Zaghloul EM; Lehto T; Lindberg S; Moreno PM; Viola JR; Magdy T; Abdo R; Guterstam P; Sillard R; Hammond SM; Wood MJ; Arzumanov AA; Gait MJ; Smith CI; Hällbrink M; Langel Ü
    Nucleic Acids Res; 2011 Jul; 39(12):5284-98. PubMed ID: 21345932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cargo molecules on membrane perturbation caused by transportan10 based cell-penetrating peptides.
    Vasconcelos L; Madani F; Arukuusk P; Pärnaste L; Gräslund A; Langel U
    Biochim Biophys Acta; 2014 Dec; 1838(12):3118-29. PubMed ID: 25135660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated peptides from melittin and its analog with high lytic activity at endosomal pH enhance branched polyethylenimine-mediated gene transfection.
    Tan YX; Chen C; Wang YL; Lin S; Wang Y; Li SB; Jin XP; Gao HW; Du FS; Gong F; Ji SP
    J Gene Med; 2012 Apr; 14(4):241-50. PubMed ID: 22328546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of acid-activated cell penetrating peptide for delivery of active molecules into cancer cells.
    Zhang W; Song J; Zhang B; Liu L; Wang K; Wang R
    Bioconjug Chem; 2011 Jul; 22(7):1410-5. PubMed ID: 21663318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
    Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
    Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides.
    Hassane FS; Abes R; El Andaloussi S; Lehto T; Sillard R; Langel U; Lebleu B
    J Control Release; 2011 Jul; 153(2):163-72. PubMed ID: 21536086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system.
    Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q
    Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
    Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
    J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-covalent strategy combining cationic lipids and CPPs to enhance the delivery of splice correcting oligonucleotides.
    Trabulo S; Resina S; Simões S; Lebleu B; Pedroso de Lima MC
    J Control Release; 2010 Jul; 145(2):149-58. PubMed ID: 20362021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of Tumor Cells Using a pH-Activated and Thermosensitive Antitumor Lipopeptide Containing a Leucine Zipper Structure.
    Wang S; Wang T; Zhang J; Xu S; Liu H
    Langmuir; 2018 Jul; 34(30):8818-8827. PubMed ID: 29914261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.